Technique for preparing amalgamation protein skin-protection product containing albuminar and skin cell growth factor, and uses of the same

A technology of human serum albumin and fusion protein, applied in the field of preparation and application of fusion protein skin care products containing human serum albumin and skin cell growth factor, which can solve the problems of short lifespan in vitro and meet the requirements of storage conditions and transportation Reduce, reduce the dosage and frequency of use, reduce the effect of cost

Active Publication Date: 2008-05-07
BEIJING MEIFUYUAN BIO PHARM TECH +2
View PDF15 Cites 33 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Since these cytokines are protein amino acid polypeptides, their in vitro lifespan is short, and various protective agents need to be added to prolong their shelf life and effective action time after application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Technique for preparing amalgamation protein skin-protection product containing albuminar and skin cell growth factor, and uses of the same
  • Technique for preparing amalgamation protein skin-protection product containing albuminar and skin cell growth factor, and uses of the same
  • Technique for preparing amalgamation protein skin-protection product containing albuminar and skin cell growth factor, and uses of the same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] Embodiment 1: the fermentation process of HSA fusion protein recombinant yeast

[0049] Several genes containing the human serum albumin gene to be expressed, the fusion gene of human serum albumin and KGF, the fusion gene of human serum albumin and bFGF, or the fusion gene of human serum albumin and hEGF (CGMCC No. 2072) or human serum albumin and hIGF fusion gene yeast colonies were cultured in basic culture medium containing Zeocin antibiotics, buffer capacity and glycerin. Cultivate on a temperature-controlled shaker at a speed of 300 rpm until the cell density reaches OD 600 = 2-6. The culture was centrifuged at 1500 rpm for 15 minutes to collect the bacteria, and the bacteria were resuspended in the same basic culture medium but without glycerol, and changed to 0.5% methanol, and the culture continued until the cell density reached OD 600 = 1.0. Under the induction of methanol, the yeast starts to express the foreign protein under the action of the promoter. T...

Embodiment 2

[0052] Embodiment 2: Separation and purification technology of HSA fusion protein

[0053] The culture supernatant expressed by recombinant yeast cells (ZY-HSA / GF) or CHO mammalian cells contains the fusion protein HSA / GF of serum albumin secreted. After centrifuging and separating the bacteria, the supernatant was treated with 0.4-1% activated carbon, collected, concentrated, and the salt concentration was reduced, then the pH was adjusted to about 7.5, and the concentrated solution was passed through the Affi-Gel Blue-Gel chromatography column manufactured by Bio-Rad Company . HSA or HSA / GF is combined with the functional group on the chromatography column and hung on the column. After washing, HSA or HSA / GF can be eluted through a 1-5M NaCl gradient to obtain a protein preparation with a purity of 75-85%. If necessary, it can be further passed through a molecular sieve chromatography column to obtain a protein preparation with a purity increased to 95-99% or more. For th...

Embodiment 3

[0054] Embodiment 3: the preparation technology of the effective component of the fermentation liquid of HSA fusion protein

[0055] If the treated fermentation supernatant is directly used for the preparation of cosmetics, it should be treated with 0.1%-10% activated carbon or diatomaceous earth. The dosage of activated carbon or diatomaceous earth is determined according to the yeast pigment (A350 / 280 absorbance value) in the fermentation broth. Preferably, 0.4%, more preferably 2% activated carbon. After the fermentation broth is decolorized, use a 20K concentration bag to concentrate to 10% of the original volume of the fermentation broth. Then desalting and changing the liquid into PB buffer solution on G25 according to the column volume ratio of 30-50%, thus obtaining the functional component (GX component) which can be used as cosmetic preparation. The GX component contains a large amount of fusion protein, yeast protein, fusion protein fragments, zymosan, etc., which...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides a recombinant fusion protein which stimulates the rejuvenation and reactivation of skin and epidermal cells for improving skin appearance, smoothing wrinkles and freckles, and whitening skin. Particularly, the present invention provides various types of products for improving skin, which contain recombinant fusion protein of human serum albumin (HSA) with cytokine peptides (EGF, FGF, KGF, HGH, HGF, PDGF, GCSF, interferon, IL-11 or IGF) by genetic engineering technology. The fusion protein can be used independently or in a combination or combination with yeast fermentation products, or with varied emulsifiers, thickeners, moisturizer, preservatives, yeasts and ferments.

Description

technical field [0001] The present invention is a continuation application of Chinese invention patents ZL021428816, ZL2004100428148 and Chinese patent application 200710057571.9. The present invention relates to a method for applying gene recombination and expressed human serum albumin fusion protein to prepare novel genetic cosmetics, and relates to the ratio of a single fusion protein or a combination of different fusion proteins, the fusion protein and yeast enzyme (polysaccharide) produced in yeast fermentation and yeast protein). In particular, it relates to the expression and production of fusion protein (HSA / GF) formed by human serum albumin (HSA) and human cell growth factor (GF) by yeast for making new cosmetics. Cell growth factor fusion proteins contained in cosmetics include, but are not limited to, human epidermal growth factor (EGF), fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), keratinocyte growth factor (KGF) And insulin-like growth ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K8/64A61K38/38A61Q19/00A61Q19/06A61P17/02C07K19/00
CPCA61K38/38A61K38/1816A61K45/06A61K9/06A61K38/1858A61K38/30C07K2319/00A61K38/193A61Q19/08A61K36/064C07K14/475A61K38/1808A61K9/0014A61K38/20A61K8/64A61K36/06A61K9/107A61Q19/02A61K38/217A61K8/9728A61P17/02A61K2300/00A61Q5/12A61Q11/00A61Q19/00
Inventor 富岩于在林
Owner BEIJING MEIFUYUAN BIO PHARM TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products